A foodborne zoonotic disease, endemic to Southeast Asia and the Pacific Islands, caused by the rat lungworm Angiostrongylus cantonensis and that is acquired by the ingestion of the infective larvae on...
Comprehensive, easy-to-understand information about this condition
How we create this content →Documentation on angiostrongyliasis is limited primarily due to its rarity and the challenges associated with studying zoonotic diseases. The condition affects fewer than 10,000 people annually in the United States, which restricts the availability of comprehensive clinical studies. Additionally, the lack of identified genetic factors and established inheritance patterns complicates the understanding of the disease's mechanisms.
The clinical picture of angiostrongyliasis is dominated by neurological symptoms due to eosinophilic meningitis. Common symptoms include headache (80-99%), fever (30-79%), vomiting (30-79%), and diplopia (30-79%). Patients may also experience irritability, excessive daytime somnolence, and other systemic symptoms such as constipation. The condition can lead to serious complications such as coma if untreated, highlighting the importance of early recognition and management.
To manage angiostrongyliasis effectively, consider consulting an infectious disease specialist with experience in zoonotic infections. They can provide insights into symptom management and potential treatment options. While no specific patient organizations are currently identified for this condition, resources such as the Centers for Disease Control and Prevention (CDC) provide valuable information on prevention and management. You can also explore general rare disease resources like GARD (rarediseases.info.nih.gov) for additional support and information.
Actionable guidance for navigating care for angiostrongyliasis
To manage angiostrongyliasis effectively, consider consulting an infectious disease specialist with experience in zoonotic infections. They can provide insights into symptom management and potential treatment options. While no specific patient organizations are currently identified for this condition, resources such as the Centers for Disease Control and Prevention (CDC) provide valuable information on prevention and management. You can also explore general rare disease resources like GARD (rarediseases.info.nih.gov) for additional support and information.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Documentation on angiostrongyliasis is limited primarily due to its rarity and the challenges associated with studying zoonotic diseases. The condition affects fewer than 10,000 people annually in the United States, which restricts the availability of comprehensive clinical studies. Additionally, the lack of identified genetic factors and established inheritance patterns complicates the understanding of the disease's mechanisms.
The clinical picture of angiostrongyliasis is dominated by neurological symptoms due to eosinophilic meningitis. Common symptoms include headache (80-99%), fever (30-79%), vomiting (30-79%), and diplopia (30-79%). Patients may also experience irritability, excessive daytime somnolence, and other systemic symptoms such as constipation. The condition can lead to serious complications such as coma if untreated, highlighting the importance of early recognition and management.
To manage angiostrongyliasis effectively, consider consulting an infectious disease specialist with experience in zoonotic infections. They can provide insights into symptom management and potential treatment options. While no specific patient organizations are currently identified for this condition, resources such as the Centers for Disease Control and Prevention (CDC) provide valuable information on prevention and management. You can also explore general rare disease resources like GARD (rarediseases.info.nih.gov) for additional support and information.
Actionable guidance for navigating care for angiostrongyliasis
To manage angiostrongyliasis effectively, consider consulting an infectious disease specialist with experience in zoonotic infections. They can provide insights into symptom management and potential treatment options. While no specific patient organizations are currently identified for this condition, resources such as the Centers for Disease Control and Prevention (CDC) provide valuable information on prevention and management. You can also explore general rare disease resources like GARD (rarediseases.info.nih.gov) for additional support and information.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Documentation on angiostrongyliasis is limited primarily due to its rarity and the challenges associated with studying zoonotic diseases. The condition affects fewer than 10,000 people annually in the United States, which restricts the availability of comprehensive clinical studies. Additionally, the lack of identified genetic factors and established inheritance patterns complicates the understanding of the disease's mechanisms.
The clinical picture of angiostrongyliasis is dominated by neurological symptoms due to eosinophilic meningitis. Common symptoms include headache (80-99%), fever (30-79%), vomiting (30-79%), and diplopia (30-79%). Patients may also experience irritability, excessive daytime somnolence, and other systemic symptoms such as constipation. The condition can lead to serious complications such as coma if untreated, highlighting the importance of early recognition and management.
To manage angiostrongyliasis effectively, consider consulting an infectious disease specialist with experience in zoonotic infections. They can provide insights into symptom management and potential treatment options. While no specific patient organizations are currently identified for this condition, resources such as the Centers for Disease Control and Prevention (CDC) provide valuable information on prevention and management. You can also explore general rare disease resources like GARD (rarediseases.info.nih.gov) for additional support and information.
Actionable guidance for navigating care for angiostrongyliasis
To manage angiostrongyliasis effectively, consider consulting an infectious disease specialist with experience in zoonotic infections. They can provide insights into symptom management and potential treatment options. While no specific patient organizations are currently identified for this condition, resources such as the Centers for Disease Control and Prevention (CDC) provide valuable information on prevention and management. You can also explore general rare disease resources like GARD (rarediseases.info.nih.gov) for additional support and information.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
Consider asking your healthcare providers these condition-specific questions
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease